Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway (original) (raw)

References

1. Lane, D.P. P53, guardian of the genome. Nature (London) 358, 15–16 (1992).
   Article CAS Google Scholar
2. Michalowitz, D., Halevy, O. & Oren, M. Conditional inhibition of transformation and cell proliferation by a temperature-sensitive mutant of p53. Cell 62, 671–680 (1990).
   Article Google Scholar
3. Bradbury, A., Possenti, R., Shooter, E.M. & Tirone, F. Molecular cloning of PCS, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc. Natl. Acad. Sci. USA 88, 3353–3357 (1991).
   Article CAS PubMed PubMed Central Google Scholar
4. Fletcher, B.S. et al. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J. Biol. Chem. 266, 14511–14518 (1991).
   CAS PubMed Google Scholar
5. Varnum, B.C., Reddy, S.T., Koski, R.A. & Herschman, H.R. Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3. J. Cell. Physiol. 158, 205–213 (1994).
   Article CAS PubMed Google Scholar
6. Rouault, J.P. et al BTG1, a member of a new family of antiproliferative genes. EMBO J. 11, 1663–1670 (1992).
   Article CAS PubMed PubMed Central Google Scholar
7. Matsuda, A. et al. Tob, a novel protein that interacts with p185erbB2, is associated with antiproliferative activity. Oncogene 12, 705–713 (1996).
   CAS PubMed Google Scholar
8. Savatier, P., Huang, S., Szekely, L., Wiman, K.G. & Samarut, J. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9, 809–818 (1994).
   CAS PubMed Google Scholar
9. Rao, P.N. in Effects of Drugs on the Cell Nucleus. 475–490 (eds Busch, H., Crooke, S.T. & Daskal, Y.) (Academic Press, New York, 1979).
   Google Scholar
10. Vogelstein, B. & Kinzler, K.W. p53 function and dysfunction. Cell 70, 523–526 (1992).
    Article CAS PubMed Google Scholar
11. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DMA damage. Cancer Res. 51, 6304–6311 (1991).
    CAS PubMed Google Scholar
12. Fields, S. & Jang, S.K. Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046–1049 (1990).
    Article CAS PubMed Google Scholar
13. Raycroft, L., Wu, H. & Lozano, G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249, 1049–1051 (1990).
    Article CAS PubMed PubMed Central Google Scholar
14. Shaw, P. et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89, 4495–4499 (1992).
    Article CAS PubMed PubMed Central Google Scholar
15. El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
    Article CAS PubMed Google Scholar
16. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. & Vogelstein, B. Definition of a consensus binding site for p53. Nature Genet. 1, 45–49 (1992).
    Article CAS PubMed Google Scholar
17. El-Deiry, W.S. et al. Topological control of P21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910–2919 (1995).
    CAS PubMed Google Scholar
18. Hartwell, L.H. & Kastan, M.B. Cell cycle control and cancer. Science 266, 1821–1828 (1994).
    Article CAS PubMed Google Scholar
19. Weinert, T.A., & Hartwell, L.H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae . Science 241, 317–322 (1988).
    Article CAS PubMed Google Scholar
20. Clarke, A.R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852 (1993).
    Article CAS PubMed Google Scholar
21. Wang, X.W. et al. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10, 188–194 (1995).
    Article CAS PubMed Google Scholar
22. Stewart, N., Hicks, G.G., Paraskevas, F. & Mowat, M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 10, 109–116 (1995).
    CAS PubMed Google Scholar
23. Aloni-Grinstein, R., Schwartz, D. & Rotter, V. Accumulation of wild-type p53 protein upon γ-irradiation induces a G2 arrest-dependent immunoglobulin κ light chain gene expression. EMBO J. 14, 1392–1401 (1995).
    Article CAS PubMed PubMed Central Google Scholar
24. Vikhanskaya, F., Erba, E., D'lncalci, M. & Broggini, M. Introduction of wildtype p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucl. Acids Res. 22, 1012–1017 (1994).
    Article CAS PubMed PubMed Central Google Scholar
25. Agarwal, M.L., Agarwal, A., Taylor, W.R. & Stark, G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493–8497 (1995).
    Article CAS PubMed PubMed Central Google Scholar
26. Powell, S.N. et al. Differential sensitivity of p53(−) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55, 1643–1648 (1995).
    CAS PubMed Google Scholar
27. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. & Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
    Article CAS PubMed Google Scholar
28. Waldman, T., Kinzler, K.W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).
    CAS PubMed Google Scholar
29. Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552–557 (1995).
    Article CAS PubMed Google Scholar
30. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
    Article CAS PubMed Google Scholar
31. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M. & Smith, J.R. Cloning of senescent cell-derived inhibitors of DMA synthesis using an expression screen. Exp. Cell Res. 211, 90–98 (1994).
    Article CAS PubMed Google Scholar
32. Hensler, P.J., Annab, L.A., Barrett, J.C & Pereira-Smith, O.M. A gene involved in control of human cellular senescence on human chromosome 1q. Mol. Cell. Biol. 14, 291–2297 (1994).
    Article Google Scholar
33. Paraskeva, C., Finerty, S. & Powell, S. Immortalization of a human colorectal adenoma cell line by continuous in vitro passage: possible involvement of chromosome 1 in tumour progression. Int. J. Cancer 41, 908–912 (1988).
    Article CAS PubMed Google Scholar
34. Mathew, C.G. et al. Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328, 524–526 (1987).
    Article CAS PubMed Google Scholar
35. Chen, L.-C., Dollbaum, C. & Smith, H.S. Loss of heterozygosity on chromosome 1q in human breast cancer. Proc. Natl. Acad. Sci. USA 86, 7204–7207 (1989).
    Article CAS PubMed PubMed Central Google Scholar
36. Cherif, D. et al. Simultaneous localization of cosmids and chromosome R-banding by fluorescence microscopy: application to regional mapping of human chromosome 11. Proc. Natl. Acad. Sci. USA 87, 6639–6643 (1990).
    Article CAS PubMed PubMed Central Google Scholar
37. Frebourg, T. et al. A functional screen for germ-line p53 mutations based on transcriptional activation. Cancer Res. 52, 6976–6978 (1992).
    CAS PubMed Google Scholar
38. Baker, S.J., Markowitz, S., Fearon, E.R., Wilson, J.K.W. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912–915 (1990).
    Article CAS PubMed Google Scholar
39. Miyashita, T., Harigai, M., Hanada, M. & Reed, J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54, 3131–3135 (1994).
    CAS PubMed Google Scholar
40. Takahashi, K., Sumimoto, H., Suzuki, K. & Ono, T. Protein-synthesis-dependent cytoplasmic translocation of p53 protein after serum stimulation of growth arrested MCF-7 cells. Mol. Carcinog. 8, 58–66 (1993).
    Article CAS PubMed Google Scholar
41. Casey, G., Lo-Hsueh, M., Lopez, M.E., Vogelstein, B. & Stanbridge, E.J. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 6, 1791–1797 (1991).
    CAS PubMed Google Scholar
42. Puisieux, A. et al. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J. 7, 1407–1413 (1993).
    Article CAS PubMed Google Scholar
43. Bartek, J., Iggo, R., Gannon, J. & Lane, D.P. Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5, 893–899 (1990).
    CAS PubMed Google Scholar
44. Bressac, B. et al. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 1973–1977 (1990).
    Article CAS PubMed PubMed Central Google Scholar

Download references